PageOverview.com
 

Domains targeting keyword no cell phone signs

Keyword no cell phone signs was used in the provided list of websites.

 
Number of websites/domains displayed: 9
Results found: 9
 

Similar searches:

 

Websites discovered:

Welcome To MiLEOX | Anti-Aging Products | Wrinkle Removal Products
http://pageoverview.com/website-report/mileox.com
MiLEOX is the revolutionary formulation that removes signs of wrinkle with its anti-aging products from sheep placenta extracts products to tomato stem cells products. The new simple way to look younger and beautiful using MiLEOX anti-wrinkle products.
  • Expected expiration: April 4th in 2018
  • Creation date: April 4th in 2012
  • Renew date: April 4th in 2017
  • Google Plus Account: +Mileox
  • Google Analytics: 50020109-1
  • AddThis User: ra-51cb5ca46d6dbbca
Laser Lab India - India's Pioneer Laser Company to Provide Complete Laser Solution
http://pageoverview.com/website-report/laserlabindia.com
Laser Lab India manufacturers, distributors, service, spares & accessories providers, for Laser machines for laser engraving, laser cutting, laser marking systems, Aesthetic, Beauty, Cosmetic , Lipo & LLLT lasers for Body Shaping, Inch Loss, Weight Reduction, Stretch Marks Reduction, Pain Rrelief & Healing, using Nd-YAG, CO2, DPSS, diode pumped, lamp pumped laser sources, hi power lasers, pin marking and engraving machines, for different applications for automotive, engineering, garment, fashion, architacture, gift and signage, macheniry manufacturing industries. Distributors of world's leading Laser companies in India like Epilog Laser, VGen, Laservall, Rofin Sinar, Precision Machineries, Precision CNC Equipment Co., Photograve, GTPE, Wavelength, etc.
  • Expected expiration: May 4th in 2018
  • Creation date: March 27th in 2000
  • Renew date: May 29th in 2011
  • Google Analytics: 36716437-1
Locate and Track Anyone by Cell Phone Number. See Who They Are Calling and Texting
http://pageoverview.com/website-report/locatecheaters.com
Locate the origin of anyone's phone in the U.S. Get their name, age, location, address, owner info and more. Enter any U.S. phone number and access the owner of that number's information. Location, name, age, address & more. If you suspect infidelity use this. Catch cheating husbands, wives, boyfriends, girlfriends, your significant other. Enter suspicious phone numbers and uncover it's owner's information.
  • Expected expiration: August 3rd in 2018
  • Creation date: August 3rd in 2016
  • Renew date: April 26th in 2017
  • Google Analytics: 97316932-1
Confronting Pancreatic Cancer: Symptoms, Signs, Causes, Treatment
http://pageoverview.com/website-report/pancreatica.org
Pancreatic cancer often has a poor prognosis, even when diagnosed early. There are rarely symptoms in the early stages of cancer of the pancreas. Find in-depth information on pancreatic cancer including adenocarcinoma of the pancreas, neuroendocrine, islet-cell, and carcinoid tumors
  • Expected expiration: May 28th in 2017
  • Creation date: May 28th in 2000
  • Renew date: May 17th in 2013
  • Google Analytics: 22720804-1
  • Google Plus Account: 110060771254337075015
Office Signs | Door Signs | Conference Room Signs | Name Plates
http://pageoverview.com/website-report/officesigncompany.com
Professional office signs, conference room signs & corporate door signs with free logos and free text. Your source for the best office sign solutions.
  • Expected expiration: September 10th in 2025
  • Creation date: September 10th in 2007
  • Renew date: March 31st in 2017
  • Google Analytics: 218077-8
  • Google Plus Account: +OfficesigncompanyFargo
Inducing Remission in GPA & MPA Patients | Rituxan® GPA & MPA | HCP
http://pageoverview.com/website-report/rituxanforgpampa-hcp.com
Find information for healthcare professionals about Rituxan® (rituximab), the only FDA-approved treatment proven to induce remission in patients with GPA and MPA. INDICATION STATEMENT - Rituxan® (rituximab), in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Limitations of Use: Rituxan is not recommended for use in patients with severe, active infections BOXED WARNINGS and Additional Important Safety Information BOXED WARNINGS Infusion Reactions: Rituxan administration can result in serious, including fatal, infusion reactions. Deaths within 24 hours of Rituxan infusion have occurred. Approximately 80% of fatal infusion reactions occurred in association with the first infusion. Monitor patients closely. Discontinue Rituxan infusion for severe reactions and provide medical treatment for Grade 3 or 4 infusion reactions. Severe Mucocutaneous Reactions: Severe, including fatal, mucocutaneous reactions can occur in patients receiving Rituxan. Hepatitis B Virus (HBV) Reactivation: HBV reactivation can occur in patients treated with Rituxan, in some cases resulting in fulminant hepatitis, hepatic failure, and death. Screen all patients for HBV infection before treatment initiation, and monitor patients during and after treatment with Rituxan. Discontinue Rituxan and concomitant medications in the event of HBV reactivation. Progressive Multifocal Leukoencephalopathy (PML): PML, including fatal PML, can occur in patients receiving Rituxan. Warnings and Precautions Rituxan administration can also result in additional serious, including fatal, adverse reactions including: - Tumor lysis syndrome (TLS): Administer aggressive intravenous hydration, anti‑hyperuricemic agents, monitor renal function - Infections: Withhold Rituxan and institute appropriate anti-infective therapy - Cardiac arrhythmias and angina: Discontinue infusions in case of serious or life-threatening events - Bowel obstruction and perforation: Consider and evaluate for abdominal pain, vomiting, or related symptoms - Live virus vaccines: Do not administer live virus vaccines prior to or during Rituxan - Cytopenias: Monitor blood counts at regular intervals Granulomatosis With Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Use of concomitant immunosuppressants other than corticosteroids has not been studied in GPA or MPA patients exhibiting peripheral B-cell depletion following treatment with Rituxan. Observe patients with GPA and MPA closely for signs of infection if immunosuppressants other than corticosteroids are used concomitantly - The safety and efficacy of retreatment with Rituxan have not been established in patients with GPA and MPA - Common adverse reactions (≥15%) in the clinical study were infections, nausea, diarrhea, headache, muscle spasms, anemia, and peripheral edema. Other important adverse reactions include infusion reactions You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. For additional safety information, please see the Rituxan full prescribing information, including BOXED WARNINGS.
  • Expected expiration: November 27th in 2019
  • Creation date: November 27th in 2013
  • Renew date: December 1st in 2017
  • Google Analytics: 48974804-1
Vinyl Decals - Superior Quality And Longer Lasting!
http://pageoverview.com/website-report/stickashack.com
Superior quality and longer lasting vinyl decals for your car, store front, wall, laptop, water bottle, cell phone, signs and more!
  • Expected expiration: December 17th in 2020
  • Creation date: December 17th in 2013
  • Renew date: March 27th in 2017
  • Google Analytics: 47480263-1
Welcome to Gasoline Advertising Product
http://pageoverview.com/website-report/gasolineadvertising.com
Gasoline Advertising Products is a leading manufacturer of the fuel dispenser price signs, pump graphic, decals, signs and image upgrade products for fueling stations and convenience store industry. GAP manufacturers and distribute quality products in range of wide variety at reasonable cost right here in the United States of America. GAP is also a leading provider of advertising signage, DOT signage, safety and compliance signage in petroleum market. We also provide products and services to Trucking and fuel carrier companies as well as AST and UST Tank and environmental company.
  • Expected expiration: December 5th in 2017
  • Creation date: December 5th in 2001
  • Renew date: November 19th in 2016
Home
http://pageoverview.com/website-report/ehlersdanlosnetwork.org
Ehlers Danlos Syndrome (EDS) is a heterogeneous group of heritable connective tissue disorders, characterized by articular (joint) hypermobility, skin extensibility and tissue fragility. Ehlers-Danlos Syndrome (EDS) is a group of inherited disorders that affect connective tissue. The body's connective tissues binds and supports the body's muscles, ligaments, organs and skin. EDS is characterized by articular (joint) There are six major types of EDS. The different types of EDS are classified according to their manifestations of signs and symptoms. Each type of EDS is a distinct disorder that "runs true" in a family. This means that an individual with Vascular Type EDS will not have a child with Classical Type EDS. Individuals with EDS have a defect in their connective tissue, the tissue which provides support to many body parts such as the skin, muscles and ligaments. The fragile skin and unstable joints found in EDS are the result of faulty collagen. Collagen is a protein which acts as a "glue" in the body adding strength and elasticity to connective tissue.
  • Expected expiration: November 29th in 2017
  • Creation date: November 29th in 2006
  • Renew date: December 1st in 2014
0.0159 // 2024-06-06 19:42:50
All Rights reserved 2018 © PageOverview.com